Calcium acetate 450 mg / magnesium carbonate 200 mg Oral Tablet [Magnebind-200]
RxNorm 213309

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 213309 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: calcium acetate 450 mg / magnesium carbonate 200 mg Oral Tablet [Magnebind-200].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Calcium acetate 450 mg / magnesium carbonate 200 mg Oral Tablet [Magnebind-200]
AUI:1170583
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Calcium acetate 450 mg / magnesium carbonate 200 mg Oral Tablet [Magnebind-200]
(Atom ID: 1170583)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
calcium acetate 450 MG / magnesium carbonate 200 MG Oral Tablet [Magnebind-200]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
213309
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
1170583
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
213309
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
09/14/2005
Date the RxNorm atom became obsolete
RXN AI
{330299} 29155
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{333917} 214342
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{330299} 1544139
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{333917} 1316581
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{330299} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{333917} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXTERM FORM
Tab
The RxTerm dose form name for this drug